Search form

Scroll To Top

hiv hepatitis policy institute

CVS Health denies coverage for  breakthrough HIV drug, committing 'clear violation' of ACA

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory factors."